about
Role of metallothioneins in benign and malignant thyroid lesionsGene expression profiling associated with the progression to poorly differentiated thyroid carcinomasA novel orthotopic mouse model of human anaplastic thyroid carcinomaBioluminescent human thyrospheres allow noninvasive detection of anaplastic thyroid cancer growth and metastases in vivoPoorly Differentiated Thyroid Carcinoma: 10-Year Experience in a Southeast Asian Population.Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71.A new aurora in anaplastic thyroid cancer therapy.MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology.A novel procedure for transtracheal resection for recurrent thyroid cancer involving a trachea and esophagusLymph node metastases do not impact survival in follicular variant papillary thyroid cancer.Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients.Epigenetics modifications and therapeutic prospects in human thyroid cancer.Neoadjuvant chemotherapy in 13 patients with locally advanced poorly differentiated thyroid carcinoma based on Turin proposal - a single institution experience.CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapyTotal thyroidectomy as primary surgical management for thyroid disease: surgical therapy experience from 5559 thyroidectomies in a less-developed region.Comprehensive literature review: recent advances in diagnosing and managing patients with poorly differentiated thyroid carcinomaComparison of Clinical and Ultrasonographic Features of Poorly Differentiated Thyroid Carcinoma and Papillary Thyroid CarcinomaImpact of lymph node ratio on survival in papillary thyroid cancer.The PLK1 inhibitor GSK461364A is effective in poorly differentiated and anaplastic thyroid carcinoma cells, independent of the nature of their driver mutationsNew developments in the diagnosis and treatment of thyroid cancer.Anaplastic thyroid cancer: ultrasonographic findings and the role of ultrasonography-guided fine needle aspiration biopsy.Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer.I-131 uptake in fat necrosis of the breast.Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas.Overall Survival of Patients with Aggressive Thyroid Cancer on Fine-Needle Aspiration Biopsy Examination. A Tertiary Romanian Center ExperienceSP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways.Establishment and characterization of cell lines from a novel mouse model of poorly differentiated thyroid carcinoma: powerful tools for basic and preclinical research.Epigenetic modifications in human thyroid cancer.Genetically engineered suicide gene in mesenchymal stem cells using a Tet-On system for anaplastic thyroid cancerInduction of apoptosis and autophagy in metastatic thyroid cancer cells by valproic acid (VPA).Emergency management of a patient with severe airway obstruction resulting from poorly differentiated thyroid carcinoma: A case report.Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumorsClinicopathological characteristics of thyroid cancer in the federal state of Salzburg.Association between prognostic factors and clinical outcome of well-differentiated thyroid carcinoma: A retrospective 10-year follow-up study.Anaplastic transformation of papillary thyroid carcinoma in multiple lung metastases presenting with a malignant pleural effusion: a case report.Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.Cytological Diagnosis of an Uncommon High Grade Malignant Thyroid Tumour: A Case Report.Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene system.Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors.Expression of Bax and Bcl2 Genes in Peripheral Blood Lymphocytes of Patients with Differentiated Thyroid Cancer.
P2860
Q28393061-32BBE010-D0E9-48A4-85B9-A417F80A14A5Q30491720-F24F9972-B878-4EFF-A88A-0A2F343F578EQ33707844-41293D34-C775-40CE-925F-188D930EB8DBQ33842338-D64F8AD5-16D4-4675-B4CF-AE1E2B23C543Q33889905-32F31286-5DFA-448F-9C78-7BF4571A089CQ33914771-32D91B9C-D0E7-4F1F-B88A-31F6F2D83FBBQ33930368-DBA3947E-EF4C-4069-BEB3-2B76E8BAE20AQ34119098-3D93F953-D8A1-4D65-AE72-C4183A6BD477Q34340327-C96D2CFA-29F3-4028-81E6-5564A371A13EQ34765342-1F5A47A2-8AB0-4920-95FF-D5AF0DC4A904Q35217023-B742C9ED-7345-4F53-A840-659A1F64E9E2Q35971504-2E0DDBA7-CAB0-4262-A700-BC6519058513Q36079263-4471F81E-F23D-4AD0-9CAB-39481F673975Q36434843-E7706195-D470-4308-8444-49972D76F45BQ36489686-69CF5287-34DA-4F3C-8E9E-467B36C12DCEQ36640992-70DFBB59-6B5B-4273-8EB4-21A8312EF9E6Q36705459-2BFBE43F-5060-4951-81DF-6C28E6F329A0Q36721796-F7B61E46-F327-4BD3-A17A-47F2FAB301F7Q37199459-EE9CFA02-A2A2-4AE3-B2A4-251419CFE89AQ37238757-EEB911D9-25B2-491B-8766-A92206DF2BE8Q37259583-A3DF8E44-DDE2-4BB4-8CE6-AB4495B5DAEDQ37613829-FD92545B-D757-460A-81E0-424D5E48DAA7Q37643295-BDCBD7FF-14E4-4DDC-B2EB-2D8915F9ECC8Q37665265-B531254A-3FDC-4501-A05B-989ACB6991DCQ37668995-51E5CB61-9083-4E11-AB33-D42147E5FD97Q38262971-FE2103C3-07C8-4548-8230-6C779D1BE3AFQ38264909-FAB8109E-DD4F-404A-9F25-EB4AE5AC0DC3Q38282099-6529B6D9-157B-43EE-8355-1EE70CC385CAQ38696750-ACA27E0E-4745-4C7A-91E8-711D4D6FB27AQ38837930-ED58B891-933E-4B91-8BC3-F0C83EDDABB5Q39236475-67FB3802-F1D6-4A0D-8336-52DEFBFC4C15Q39424181-2BC0684D-2111-4A14-986E-7C8AB38CFCABQ40206178-70DEB0DB-68C6-4985-B46D-C348D41968C2Q40257719-D6DFD1FF-0E50-43F9-BA52-8D9EF6BED9A1Q41776720-CB6383A4-0319-4553-A472-4D1D584ECABEQ48088782-27CF7AC7-E2D4-48F8-A5A8-673FF992B531Q50151708-27A2D423-6ED2-4635-8F21-2DF8FAFCB786Q52691334-D2B57C0A-70F3-41E2-A393-4B80AEAFE3AEQ52778675-4D7F27E4-CC3D-44D9-A3E1-5A026E0E4763Q55006046-9CB80520-A698-4484-AF31-0A473CEF3E66
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Poorly differentiated and anaplastic thyroid cancer.
@ast
Poorly differentiated and anaplastic thyroid cancer.
@en
type
label
Poorly differentiated and anaplastic thyroid cancer.
@ast
Poorly differentiated and anaplastic thyroid cancer.
@en
prefLabel
Poorly differentiated and anaplastic thyroid cancer.
@ast
Poorly differentiated and anaplastic thyroid cancer.
@en
P2860
P1433
P1476
Poorly differentiated and anaplastic thyroid cancer.
@en
P2093
Ashok R Shaha
Kepal N Patel
P2860
P304
P356
10.1177/107327480601300206
P577
2006-04-01T00:00:00Z